Delivery Order 36F79722D0090-36C26325F0017
Award Date
10/11/24
Potential Completion Date
4/30/25
Potential Value
$138K
Federal Agency
Veterans Integrated Service Network 23
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90032, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Grifols USA LLC is for the delivery of PROLASTIN-C LIQUID, a 1000mg/vial alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The $499,680.00 firm fixed-price contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2024 by the Department of Veterans Affairs' Veterans Integrated Service Network 20. The contract is not set-aside and is issued under Grifols' Federal Supply Schedule (FSS-61-IB) contract for...
The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation,...
The Department of Veterans Affairs Veterans Health Administration awarded a $109,200 delivery order contract to Grifols USA LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule. The contract calls for Grifols to provide PROLASTIN-C, a drug used to treat alpha-1 antitrypsin deficiency, to facilities located in Los Angeles, California. The base period of performance is one year, from February 8, 2024 through February 7, 2025. Pricing is firm fixed. No subcontractors or...
This federal contract award is for the delivery of PROLASTIN-C 1000MG VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is a Delivery Order under Grifols' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
This is a $319,369.68 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which is not set aside, is for the delivery of the pharmaceutical product PROLASTIN C. It is a firm fixed price contract with a period of performance ending on September 30, 2020. Grifols Therapeutics LLC is a long-standing federal contractor, having...
This is a delivery order for PROLASTIN MEDICATION awarded by the Veterans Integrated Service Network 21 (VISN 21) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, which is not set-aside, has a ceiling value of $144,000.00 and a period of performance ending on September 30, 2017. The award was made under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule contract vehicle. Grifols Therapeutics has previously provided...
This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
This is a federal contract award for PROLASTIN, a pharmaceutical product, issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule 61-IB. The contract is a delivery order with a firm fixed price of $75,000.00 and a period of...
This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a regional network within the U.S. Department of Veterans Affairs (VA), to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C, a drug product, and has a ceiling value of $100,281.60. The contract was awarded on a Firm Fixed Price basis under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB)...
The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...